stathmin 1
Recently Published Documents


TOTAL DOCUMENTS

90
(FIVE YEARS 13)

H-INDEX

18
(FIVE YEARS 1)

2021 ◽  
Vol 43 ◽  
pp. S179-S180
Author(s):  
HP Vicari ◽  
JL Coelho-Silva ◽  
DA Pereira-Martins ◽  
K Lima ◽  
JCL Silva ◽  
...  
Keyword(s):  

2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Sofia Liou ◽  
Neshat Nilforoushan ◽  
Yuna Kang ◽  
Neda A. Moatamed

Abstract Background The aim of this study was to determine how Stathmin-1 and Heat Shock Protein 27 (HSP27) can be used as adjunctive biomarkers to differentiate high-grade dysplasia from benign/reactive lesions in cervical tissues. In addition, we aimed to see if any of these markers can differentiate endometrial from endocervical adenocarcinomas. Methods Fifty cases including benign cervical tissue, low-grade squamous intraepithelial lesion (LSIL), high-grade squamous intraepithelial lesion (HSIL), adenocarcinoma in situ of the endocervix, invasive endocervical adenocarcinoma, and endometrial adenocarcinoma were selected. Stathmin-1 and HSP27 immunohistochemistry (IHC) were performed for each case and the results were compared to the previously available p16 IHC stains. Results p16 stained positively in 100% of HSIL, endocervical adenocarcinoma in situ, and invasive endocervical cases. Stathmin-1 stained positively in 43% of HSIL and 90% of endocervical adenocarcinoma in situ and all invasive endocervical cases. Stathmin-1 and p16 were negative in all benign cervical samples. Stathmin-1, HSP27, and p16 stained 100% of LSIL cases. HSP27 stained indiscriminately, including 100% of benign cervical tissue. 87% of the endometrial adenocarcinomas stained positively for p16, Stathmin-1, and HSP27. Conclusion p16 remains superior to both Stathmin-1 and HSP27 in differentiating dysplasia from benign, reactive changes of the cervix.


2021 ◽  
Vol 567 ◽  
pp. 106-111
Author(s):  
Selase D. Deletsu ◽  
Haruki Kitamura ◽  
Takaomi Ishida ◽  
Jin Gohda ◽  
Shoji Yamaoka ◽  
...  

2021 ◽  
Vol 87 ◽  
pp. 102522
Author(s):  
Charmaine A. Ramlogan-Steel ◽  
Jason C. Steel ◽  
Hassana Fathallah ◽  
Camelia Iancu-Rubin ◽  
George F. Atweh

2020 ◽  
Vol 42 ◽  
pp. 154
Author(s):  
J.A.E.G. Carlos ◽  
K. Lima ◽  
L.V. Costa-Lotufo ◽  
A. Leitão ◽  
J.A. Machado-Neto

2020 ◽  
Vol 11 (9) ◽  
Author(s):  
Yan Zhou ◽  
Yalin Wang ◽  
Sai Wu ◽  
Yuting Yan ◽  
Yabin Hu ◽  
...  

Abstract Here we uncovered the involved subcellular mechanisms that sulforaphane-cysteine (SFN-Cys) inhibited invasion in human glioblastoma (GBM). SFN-Cys significantly upregulated 45 and downregulated 14 microtubule-, mitophagy-, and invasion-associated proteins in GBM cells via HPLC–MS/MS and GEO ontology analysis; SFN-Cys disrupted microtubule by ERK1/2 phosphorylation-mediated downregulation of α-tubulin and Stathmin-1 leading to the inhibition of cell migration and invasion; SFN-Cys downregulated invasion-associated Claudin-5 and S100A4, and decreased the interaction of α-tubulin to Claudin-5. Knockdown of Claudin-5 and S100A4 significantly reduced the migration and invasion. Besides, SFN-Cys lowered the expressions of α-tubulin-mediated mitophagy-associated proteins Bnip3 and Nix. Transmission electron microscopy showed more membrane-deficient mitochondria and accumulated mitophagosomes in GBM cells, and mitochondria fusion might be downregulated because that SFN-Cys downregulated mitochondrial fusion protein OPA1. SFN-Cys increased the colocalization and interplay of LC3 to lysosomal membrane-associated protein LAMP1, aggravating the fusion of mitophagosome to lysosome. Nevertheless, SFN-Cys inhibited the lysosomal proteolytic capacity causing LC3II/LC3I elevation but autophagy substrate SQSTM1/p62 was not changed, mitophagosome accumulation, and the inhibition of migration and invasion in GBM cells. These results will help us develop high-efficiency and low-toxicity anticancer drugs to inhibit migration and invasion in GBM.


2020 ◽  
Vol 133 (14) ◽  
pp. jcs248591
Author(s):  
Sabine A. G. Cuijpers ◽  
Edwin Willemstein ◽  
Jan G. Ruppert ◽  
Daphne M. van Elsland ◽  
William C. Earnshaw ◽  
...  

ABSTRACTCell division ends when two daughter cells physically separate via abscission, the cleavage of the intercellular bridge. It is not clear how the anti-parallel microtubule bundles bridging daughter cells are severed. Here, we present a novel abscission mechanism. We identified chromokinesin KIF4A, which is adjacent to the midbody during cytokinesis, as being required for efficient abscission. KIF4A is regulated by post-translational modifications. We evaluated modification of KIF4A by the ubiquitin-like protein SUMO. We mapped lysine 460 in KIF4A as the SUMO acceptor site and employed CRISPR-Cas9-mediated genome editing to block SUMO conjugation of endogenous KIF4A. Failure to SUMOylate this site in KIF4A delayed cytokinesis. SUMOylation of KIF4A enhanced the affinity for the microtubule destabilizer stathmin 1 (STMN1). We here present a new level of abscission regulation through the dynamic interactions between KIF4A and STMN1 as controlled by SUMO modification of KIF4A.


2019 ◽  
Vol 4 (1) ◽  
pp. 38-49 ◽  
Author(s):  
Enpeng Zhao ◽  
Yang Shen ◽  
Muhammad Amir ◽  
Alton B. Farris ◽  
Mark J. Czaja

2019 ◽  
Vol 38 (3) ◽  
pp. 899-908 ◽  
Author(s):  
Bárbara dos Santos Passaia ◽  
Keli Lima ◽  
Jean Lucas Kremer ◽  
Barbara Brito da Conceição ◽  
Beatriz Marinho de Paula Mariani ◽  
...  

2019 ◽  
Vol 108 (1) ◽  
pp. 235-243
Author(s):  
Kimihiro Shimizu ◽  
Yusuke Goto ◽  
Reika Kawabata-Iwakawa ◽  
Yoichi Ohtaki ◽  
Seshiru Nakazawa ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document